Company Number: 14102193

Analysis Date: 2025-07-29 16:39 UTC

1. Industry Classification
   Precision Neurosurgery Ltd operates within the SIC code 86220 — Specialists medical practice activities. This sector comprises medical professionals offering specialised clinical services, often requiring advanced expertise and equipment. Key characteristics include high regulatory oversight, dependence on skilled practitioners (in this case, neurosurgeons), and a focus on patient outcomes. The industry typically involves a mix of private specialists, NHS contracts, and private healthcare providers. The sector is capital intensive in terms of specialist equipment and clinical infrastructure, and revenue generation depends heavily on patient volume and service complexity.

2. Relative Performance
   As a company incorporated in 2022 and filing accounts for the financial years ending May 2023 and May 2024, Precision Neurosurgery Ltd is very much in its infancy stage. The reported turnover is effectively zero (£0 in 2024, £1,788 in 2023), which is far below typical benchmarks for established specialist medical practices in the UK, where annual revenues often range from hundreds of thousands to multiple millions of pounds depending on scale and service mix. The net assets stand at a nominal £9–£10, reflecting minimal fixed/intangible assets and no significant current liabilities or debts. Administrative expenses are low but exceed turnover, resulting in a small operating loss (~£1,891 in 2024). This financial profile is consistent with a start-up or early-stage specialist practice yet to fully commercialise its services or patient base.

3. Sector Trends Impact
   The specialist medical practice sector is influenced by multiple trends:

• Increasing demand for neurosurgical and specialist neurological services driven by an aging population and rising prevalence of neurological disorders.
• Growing NHS outsourcing and partnerships with private specialists to manage waiting lists, which could present future revenue opportunities.
• Technological advancements in minimally invasive neurosurgery and precision medicine requiring continuous investment in training and equipment.
• Regulatory and compliance costs remain high, particularly regarding patient safety and data protection.
• COVID-19 had a short-term impact on elective specialist procedures, but recovery and backlog management provide medium-term growth potential.

Precision Neurosurgery Ltd’s early-stage status means it is likely navigating initial setup challenges, regulatory approvals, and market entry hurdles. Its ability to leverage sector growth trends depends on successful patient acquisition, partnership formation, and investment in clinical capabilities.

4. Competitive Positioning
   Currently, Precision Neurosurgery Ltd is a micro-entity with two directors (one a neurosurgeon), limited financial resources, and no significant operating revenue. Compared to established specialist medical practices or larger neurosurgery providers, it is a niche entrant with minimal scale and market penetration. Strengths may include focused clinical expertise and agility in decision-making. Weaknesses include lack of revenue, limited assets, and minimal operational history to build credibility and referral networks. The company's private limited status protects shareholders but also limits capital raising options relative to larger public or NHS-affiliated entities.

The competitive landscape in UK specialist medical practice is dominated by NHS hospitals, large private hospital groups (e.g., Ramsay Health Care, BMI Healthcare), and specialist clinics with established reputations and referral pathways. For Precision Neurosurgery Ltd to move beyond a follower or niche player role, it will need to build clinical volume, secure contracts (both private and potentially NHS), and invest in marketing and infrastructure.